Silver Book Fact

Aspirin use in AFib patients

Meta-analysis of a number of randomized controlled trials found that aspirin use in atrial fibrillation patients
reduced stroke risk by an average 22%.

Hart, RG, O Benavente, R McBride, and LA Pearce. Antithrombotic Therapy to Prevent Stroke in Patients with Atrial Fibrillation. Ann Intern Med. 1999; 131(7): 492-501. http://www.annals.org/content/131/7/492.1.full

Reference

Title
Antithrombotic Therapy to Prevent Stroke in Patients with Atrial Fibrillation
Publication
Ann Intern Med
Publication Date
1999
Authors
Hart, RG, O Benavente, R McBride, and LA Pearce
Volume & Issue
Volume 131, Issue 7
Pages
492-501
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Effectiveness of pacemaker/defibrillators to control AFib
    Widespread use of pacemaker/defibrillators to control atrial fibrillation could result in a 50% decrease in stroke.  
  • AFib practice guidelines reduce direct health care costs
    The use of practice guidelines in atrial fibrillation (AF) patients significantly decreased hospitalization and resource utilization—with an average decrease in 30-day total direct health care costs of around $1,400 per patient.  
  • Stroke risk reduction from thrombin inhibitor in AFib patients
    A recently approved direct thrombin inhibitor was found to reduce the risk of stroke/peripheral embolic events in atrial fibrillation patients by 34%, and the risk of hemorrhagic stroke by 74%—compared…  
  • Catheter ablation reduces risk of stroke and death among AFib patients
    Atrial fibrillation patients who underwent catheter ablation had a reduced risk of stroke and death—2.2% of those who had ablation experienced stroke versus 4.7% on medications alone, and 6% died from…  
  • Cost of warfarin therapy for AFib patients
    In patients with nonvalvular atrial fibrillation (AF) and one additional stroke risk factor, warfarin therapy cost $8,000 per quality-adjusted life-year (QALY) saved.